Skip to main content

Peer Review reports

From: The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis

Original Submission
9 Mar 2020 Submitted Original manuscript
4 Apr 2020 Reviewed Reviewer Report - Hie-Won Hann
22 Jun 2020 Reviewed Reviewer Report
7 Jul 2020 Reviewed Reviewer Report
13 Aug 2020 Author responded Author comments - Dan Peng
Resubmission - Version 2
13 Aug 2020 Submitted Manuscript version 2
25 Aug 2020 Reviewed Reviewer Report
14 Sep 2020 Reviewed Reviewer Report - Marcello Persico
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
28 Sep 2020 Editorially accepted
19 Oct 2020 Article published 10.1186/s12876-020-01477-8

You can find further information about peer review here.

Back to article page